Screener
Twist Bioscience Corporation TWST Contract Liabilities
Contract Liabilities at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiability.
The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001581280-26-000040
FAQ
- What is Twist Bioscience Corporation's contract liabilities?
- Twist Bioscience Corporation (TWST) reported contract liabilities of $7.1M in Q1 2026.
- How has Twist Bioscience Corporation's contract liabilities changed year-over-year?
- Twist Bioscience Corporation's contract liabilities increased by 256.9% year-over-year, from $1.99M to $7.1M.
- What is the long-term trend for Twist Bioscience Corporation's contract liabilities?
- Over 3 years (2022 to 2025), Twist Bioscience Corporation's contract liabilities has grown at a 25.3% compound annual growth rate (CAGR), from $3.5M to $6.88M.
- What does contract liabilities mean?
- Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.
Ask your AI about Twist Bioscience Corporation's contract liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude